Ischemia-driven angiogenesis

Trends in Cardiovascular Medicine

Volumn 7, Issue 8, 1997, Pages 289-294

  Dor, Yuval ^a   Keshet, Eli ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; DIABETIC RETINOPATHY; HYPOXIA; ISCHEMIA; NEOVASCULARIZATION (PATHOLOGY); OXYGEN CONSUMPTION; PRIORITY JOURNAL; RETINOPATHY; REVIEW; TRANSCRIPTION REGULATION; TUMOR GROWTH;

EID: 0030712335     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00091-1     Document Type: Review

References (64)

1. Adamis AP, Miller JW, Bernal MT, et al.: 1994. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 118: 445-450.
2. Aiello LP, Avery RL, Arrigg PG, et al.: 1994. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders [see comments]. N Engl J Med 331:1480-1487.
3. Alon T, Hemo I, Itin A, Pe'er J, Stone J, Keshet E: 1995. VEGF acts as a survival factor for newly-formed retinal vessies: implications for retinopathy of prematurity. Nat Med 1:1024-1028.
4. Asahara T, Bauters C, Zheng LP, et al.: 1995. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92:365-371.
5. Ashton N: 1957. Retinal vascularizion in health and disease. Am J Ophthalmol 44:7-17.
6. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E: 1994. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 28:1176-1179.
7. Black JE, Sirevaag AM, Greenough WT: 1987. Complex experience promotes capillary formation in young rat visual cortex. Neurosci Lett 83:351-355.
8. Davis S, Aldrich TH, Jones PF, et al.: 1996. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169.
9. Ferrara N: 1995. The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat 36:127-137.
10. Folkman, J: 1995. Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763.
11. Forsythe JA, Jiang BH, Iyer NV, et al.: 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613.
12. Freeman MR, Schneck FX, Gagnon ML, et al.: 1995. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Res 55:4140-4145.
13. Giordano FJ, Ping P, McKirnan MD, et al.: 1996. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 2:534-539.
14. Goto F, Goto K, Weindel K, Folkman J: 1993. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69:508-517.
15. Huang LE, Arany Z, Livingston DM, Bunn HF: 1996. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit. J Biol Chem 271:32,253-32,259.
16. Hunt TK, Knighton DR, Thakral KK, Goodson WHD, Andrews WS: 1984. Studies on inflammation and wound healing: angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages. Surgery 96:48-54.
17. Ikeda E, Achen MG, Breier G, Risau W: 1995. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J Biol Chem 270:19,761-19,766.
18. Isner JM, Pieczek A, Schainfeld R, et al.: 1996. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348:370-374.
19. Knighton DR, Silver IA, Hunt TK: 1981. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery 90:262-270.
20. Knighton DR, Hunt TK, Scheuenstuhl H, Halliday BJ, Werb Z, Banda MJ: 1983. Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221: 1283-1285.
21. Koch AE, Polverini PJ, Kunkel SL, et al.: 1992. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801.
22. Kourembanas S, Hannan RL, Faller DV: 1990. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest 86:670-674.
23. Kovacs Z, Ikezaki K, Samoto K, Inamura T, Fukui M: 1996. VEGF and fit: Expression time kinetics in rat brain infarct. Stroke 27: 1865-1872.
24. Kuwabara K, Ogawa S, Matsumoto M, et al.: 1995. Hypoxia-mediated induction of acidic/ basic fibroblast growth factor and platelet-derived growth factor in mononuclear ph-agocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci USA 92:4606-4610.
25. Leveen P, Penky M, Gebre-Medhin S, Swolin B, Larsson E, Betsholtz C: 1994. Mice deficient for PDGF-B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8:1875-1887.
26. Levy AP, Levy NS, Goldberg MA: 1996a. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA and its modulation by the von Hippel-Lindau protein. J Biol Chem 271:25,492-25,497.
27. Levy AP, Levy NS, Goldberg MA: 1996b. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271:2746-2753.
28. Liu Y, Cox SR, Monta T, Kourembanas S: 1995. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5′ enhancer. Circ Res 77:638-643.
29. Mazure NM, Chen EY, Yeh P, Laderoute KR, Giaccia AJ: 1996. Oncogenic transformation and hypoxia synergistically act to modulate vascular endothelial growth factor expression. Cancer Res 56:3436-3640.
30. Michaelson IC: 1948. The mode of development of the vascular system of the retina, with some observations on its significance for certain retinal diseases. Trans Ophthalmol Soc UK 65:137-180.
31. Miller JW, Adamis AP, Shima DT, et al.: 1994. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145:574-584.
32. Minchenko A, Bauer T, Salceda S, Caro, J: 1994. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Lab Invest 71:374-379.
33. Namiki A, Brogi E, Kearney M, et al.: 1995. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells. J Biol Chem 270:31,189-31,195.
34. Pe'er J, Shweiki D, Itin A, Hemo I, Gnessin H, Keshet E: 1995. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. Lab Invest 72:638-645.
35. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E: 1996. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 80:241-245.
36. Plate KH, Breier G, Weich HA, Risau W: 1992. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848.
37. Plate KH, Breier G, Millauer B, Ullrich A, Risau W: 1993. Up-regulation of vascular endothelial growth factor and its cognate receptors in a rat glioma model of tumor angiogenesis. Cancer Res 53:5822-5827.
38. Risau W, Flamme I: 1995. Vasculogenesis. Ann Rev Cell Dev Biol 11:73-91.
39. Salceda S, Beck I, Caro J: 1996. Absolute requirement of aryl hydrocarbon receptor nuclear translocator protein for gene activation by hypoxia. Arch Biochem Biophys 334:389-394.
40. Semenza GL: 1996. Transcriptional regulation by hypoxia-inducible factor-1. Trends Cardiovasc Med 6:151-157.
41. Shima DT, Deutsch U, D'Amore PA: 1995. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett 370:203-208.
42. Shweiki D, Itin A, Soffer D, Keshet E: 1992. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia- initiated angiogenesis. Nature 359:843-845.
43. Shweiki D, Neeman M, Itin A, Keshet E: 1995. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci USA 92:768-772.
44. Simons M, Ware JA: 1996. Food for starving hearts. Nat Med 2:519-520.
45. Stein I, Neeman M, Shweiki D, Itin A, Keshet E: 1995. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol Cell Biol 15:5363-5368.
46. Stone J, Itin A, Alon T, et al.: 1995. Development of retinal vasculature is mediated by hypoxiainduced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15:4738-4747.
47. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C: 1994. Macrophages and angiogenesis. J Leukoc Biol 55:410-422.
48. Suri C, Jones PF, Patan S, et al.: 1996. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87:1171-1180.
49. Takagi H, King GL, Ferrara N, Aiello LP: 1996. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci 37:1311-1321.
50. Takeshita S, Rossow ST, Kearney M, et al.: 1995. Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am J Pathol 147:1649-1660.
51. Takeshita S, Tsurumi Y, Couffinahl T, et al.: 1996a. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab Invest 75:487-501.
52. Takeshita S, Weir L, Chen D, et al.: 1996b. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem Biophys Res Commun 227:628-635.
53. Thomas KA: 1996. Vascular endothelial growth factor, a potent and selective angiogenic agent. J Biol Chem 271:603-606.
54. Tian H, McKnight SL, Russel DW: 1997. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev 11:72-82.
55. Tuder RM, Flook BE, Voelkel NF: 1995. Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Fit in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide. J Clin Invest 95:1798-1807.
56. Unger EF, Banai S, Shou M, et al.: 1994. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol 266:H1588-H1595.
57. Vikkula M, Boon LM, Carraway KL, et al.: 1996. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 87:1181-1190.
58. Waltenberger J, Mayr U, Pentz S, Hombach V: 1996. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia. Circulation 94:1647-54.
59. Ware JA, Simons M: 1997. Angiogenesis in ischemic heart disease. Nat Med 3:158-163.
60. Weihrauch D, Zimmermann R, Arras M, Schaper, J: 1994. Expression of extracellular matrix proteins and the role of fibroblasts and macrophages in repair processes in ischemic porcine myocardium. Cell Mol Biol Res 40:105-116.
61. Williams JK, Armstrong ML, Heistad DD: 1988. Vasa vasorum in atherosclerotic coronary arteries: responses to vasoactive stimuli and regression of atherosclerosis. Circ Res 62: 515-523.
62. Wood SM, Gleadle JM, Pugh CW, Hankinson O, Ratcliffe PJ: 1996. The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells. J Biol Chem 271:15,117-15,123.
63. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al.: 1992. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257:1401-1403.
64. Zemplenyi T, Crawford DW, Cole M.: 1989. Adaptation to arterial wall hypoxia demonstrated in vivo with oxygen microcathodes. Atherosclerosis 76:173-179.